Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer
- 1 December 1989
- journal article
- research article
- Published by Springer Nature in Archiv für Gynäkologie
- Vol. 244 (4) , 193-206
- https://doi.org/10.1007/bf01560083
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Hohe CA-125-Serumspiegel bei benignem Aszites oder PleuraergußGeburtshilfe und Frauenheilkunde, 1987
- The clinical significance of pre-operative serum CA 125 in ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomyEuropean Journal of Cancer and Clinical Oncology, 1987
- CA-125 in gynecological malignanciesEuropean Journal of Cancer and Clinical Oncology, 1987
- Chemotherapie des DysgerminomsGeburtshilfe und Frauenheilkunde, 1987
- Radioimmunszintigraphie beim Ovarialkarzinom: Theoretische Grundlagen und klinische ErfahrungenArchiv für Gynäkologie, 1987
- Serum CA 125 in epithelial ovarian cancer. A longitudinal studyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Increased Serum Ca 125 Levels During the First Trimester of PregnancyActa Obstetricia et Gynecologica Scandinavica, 1986
- Serum CA 125 in Ovarian Pathology and Its Variation in Ovarian Carcinoma after Integrated TherapyGynecologic and Obstetric Investigation, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983